FEATURED NEWS
NEWS: ASGCT ANNUAL MEETING NEWS RELEASE (MAY 2024)
As the global leader in lipid nanoparticle delivery systems, Acuitas scientists, Dr. Ying Tam and Sean Semple, will deliver poster presentations at the American Society of Gene + Cell Therapy Annual Meeting. Click to read the news release.
NEWS: MRNA-LNP VACCINE-INDUCED CD8+ T-CELLS PROTECT MICE FROM LETHAL SARS-COV-2 INFECTION IN THE ABSENCE OF SPECIFIC ANTIBODIES (APR 2024)
Congratulations to Ying Tam and Molly Sung, co-authors of a recent study featured in Molecular Therapy. They collaborated with scientists from Thomas Jefferson University using mouse-adapted SARS-CoV-2 virus (MA30) in C57BL/6 mice, showing that CD8+ T cells are unnecessary for the intrinsic resistance of female or the susceptibility of male mice to lethal SARS-CoV-2 infection. Click to read more info.
NEWS: MUTATION-GUIDED VACCINE DESIGN: A PROCESS FOR DEVELOPING BOOSTING IMMUNOGENS FOR HIV BROADLY NEUTRALIZING ANTIBODY INDUCTION (APR 2024)
Congratulations to Ying Tam and Chris Barbosa, co-authors of a recent study featured in Cell Host & Microbe. They collaborated with scientists from the Duke University School of Medicine demonstrating a process for designing boosting immunogens for a V3-glycan bnAb B cell lineage. Click to read more info.